Stock listing

TWSE:6949 PELL Bio-Med Technology Co Ltd (沛爾生醫*-創) 股價

Follow PELL Bio-Med Technology Co Ltd into a list and get an email when it puts out news.

Share price · TWSE:6949

$36.65 TWD -8.40 (-18.6%)

Close on Nov 20, 2026

Past year -90.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$36.65 – $40.00 TWDNov 20, 2026
Volume
4.77M sharesNov 20, 2026
Market cap
$48.05B TWDAt the close on Nov 20, 2026 · price × 1.31B shares outstanding
52-week range
$34.75 – $1,490.00 TWDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.35B TWDMedian day 3.88M shares · 8 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
PELL Bio-Med Technology Co Ltd logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · TWSE:6949 · TWD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$36.65-8.40-18.6%$40.00$40.00$36.654,768,599
$45.05-0.30-0.7%$46.70$48.45$43.004,823,430
$45.35-4.15-8.4%$44.95$50.90$44.7014,994,906
$49.50+4.50+10.0%$49.50$49.50$48.006,202,983
$45.00+4.05+9.9%$41.80$45.00$41.455,593,543
$40.95-3.80-8.5%$49.20$49.20$40.5523,707,219
$44.75+3.20+7.7%$41.05$44.80$41.054,283,589
$41.55+1.50+3.7%$42.05$42.25$39.855,376,104
$40.05+2.50+6.7%$37.60$41.30$37.602,174,975
$37.55-1.05-2.7%$35.55$37.90$35.252,903,043
$38.60-0.85-2.2%$39.40$41.90$37.803,828,383
$39.45+0.25+0.6%$39.30$39.75$37.052,252,725
$39.20-1.65-4.0%$40.55$41.00$39.202,048,719
$40.85+1.80+4.6%$38.10$41.65$38.102,119,257
$39.05-1.75-4.3%$40.05$40.45$37.802,455,555
$40.80+1.15+2.9%$40.00$41.50$39.502,954,244
$39.65+0.10+0.3%$39.55$40.80$39.351,749,138
$39.55+1.85+4.9%$38.70$41.45$38.453,661,662
$37.700.000.0%$37.70$37.70$37.700
$37.70-1.40-3.6%$39.35$39.85$37.601,720,641
$39.10+1.90+5.1%$40.25$40.90$38.207,368,020
$37.20+1.30+3.6%$36.00$39.45$34.757,057,261
$35.90-3.00-7.7%$39.30$39.30$35.605,402,283
$38.90-0.10-0.3%$39.45$39.80$38.102,939,300
$39.00-0.40-1.0%$40.00$40.95$38.403,954,938
$39.40-2.65-6.3%$42.00$42.00$38.0016,638,650
$42.05-4.65-10.0%$45.30$45.85$42.056,243,130
$46.70-0.15-0.3%$46.85$47.50$45.303,326,100
$46.85+1.55+3.4%$45.65$47.15$44.952,287,282
$45.30-1.45-3.1%$46.60$47.70$44.852,319,027
$46.75-0.85-1.8%$47.95$48.90$46.651,848,201
$47.60+3.10+7.0%$45.20$48.10$44.353,927,603
$44.50-4.90-9.9%$48.85$49.20$44.5013,887,439
$49.40-1.20-2.4%$50.00$50.80$49.002,111,120
$50.60+1.40+2.8%$49.50$51.50$49.352,953,550
$49.20-1.10-2.2%$49.85$51.50$48.453,035,002
$50.300.000.0%$49.10$50.30$49.102,648,460
$50.30-0.50-1.0%$49.25$51.00$49.252,829,500
$50.80-3.00-5.6%$53.00$53.80$50.603,585,286
$53.80-0.70-1.3%$54.00$54.90$53.002,687,800
$54.50+0.10+0.2%$54.50$58.50$53.208,209,800
$54.40+1.30+2.4%$51.60$55.30$51.604,485,935
$53.10+1.70+3.3%$50.50$53.30$50.004,256,112
$51.40-4.40-7.9%$54.80$56.00$51.007,357,700
$55.80+2.80+5.3%$50.00$56.90$48.257,757,200
$53.00-5.80-9.9%$55.90$60.10$53.0013,476,470
$58.80+3.90+7.1%$56.80$60.30$55.4025,963,175
$54.90-5.50-9.1%$59.80$60.40$54.4034,416,198
$60.40-6.70-10.0%$60.40$62.70$60.4018,467,625
$67.10-7.40-9.9%$81.90$81.90$67.1024,344,655
$74.500.000.0%$74.50$74.50$74.500
$74.500.000.0%$74.50$74.50$74.500
$74.500.000.0%$74.50$74.50$74.500
$74.50-1,415.50-95.0%$74.50$74.50$74.500
$1,490.000.000.0%$1,490.00$1,490.00$1,490.000
$1,490.000.000.0%$1,490.00$1,490.00$1,490.000
$1,490.000.000.0%$1,490.00$1,490.00$1,490.000
$1,490.00+135.00+10.0%$1,405.00$1,490.00$1,400.0011,001,520
$1,355.00+120.00+9.7%$1,250.00$1,355.00$1,225.0019,141,000
$1,235.00+80.00+6.9%$1,180.00$1,260.00$1,165.0010,240,400
$1,155.00+30.00+2.7%$1,140.00$1,190.00$1,140.005,006,800
$1,125.00+40.00+3.7%$1,105.00$1,130.00$1,075.005,440,420

Splits

1 split · TWSE:6949 · every price before a split is adjusted for it

DayRatioWhat
20-for-1Split
Ticker
TWSE:6949
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TWSE
Currency
TWD

PELL Bio-Med Technology Co Ltd on 6ix

Sector
Health care
Industry
Biotechnology

Valuation

EV/sales 1,591× against a median of 15.5×: the highest of 8 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$46.01B TWD
P/E
Loss
EV/sales
1,591×
EV/EBITDA
Negative EBITDA
Price/book
18.7×
Gross margin
−49.4%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.1×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PELL Bio-Med Technology Co Ltd · TWSE:6949US$1.46BUS$1.40Bn/a1,591×n/a18.7×n/a0.1×n/a
ABL Bio, Inc. · KRX:298380US$1.48BUS$1.35Bn/a52.7×n/a11.5×−229.4%0.0×n/a
Alvotech · NASDAQ:ALVOUS$1.47BUS$2.78Bn/a5.7×31.4×n/a−36.5%n/a0.90
Mesoblast Limited · ASX:MSBUS$1.46BUS$1.42Bn/a82.4×n/a2.4×−593.9%0.2×n/a
Voronoi, Inc. · KRX:310210US$1.44BUS$1.40Bn/an/an/a27.9×n/a0.5×n/a
Damora Therapeutics, Inc. · NASDAQ:DMRAUS$1.44BUS$910.0Mn/an/an/a2.9×n/a0.0×0.88
Vir Biotechnology, Inc. · NASDAQ:VIRUS$1.44BUS$1.07Bn/a3.5×n/a1.6×−61.0%0.1×1.82
LigaChem Biosciences Inc. · KRX:141080US$1.43BUS$1.15Bn/a15.5×n/a4.8×−180.9%0.0×n/a
Kailera Therapeutics, Inc. · NASDAQ:KLRAUS$1.43BUS$539.5Mn/an/an/a1.4×n/a0.0×1.28
Sarepta Therapeutics, Inc. · NASDAQ:SRPTUS$1.43BUS$1.41Bn/a0.7×n/a0.9×−5.9%0.6×1.70
ADARx Pharmaceuticals, Inc. · NASDAQ:ADRXUS$1.42BUS$521.8Mn/a77.6×n/a2.5×n/a0.0×n/a
Median of the othersUS$1.44BUS$1.25B15.5×31.4×2.5×−121.0%0.0×1.28

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue31.4M19.6M18.0M17.2M14.0M
Cost of revenue35.8M32.0M44.2M59.5M48.5M
Gross profit-4.39M-12.3M-26.1M-42.3M-34.5M
Research and development252.7M266.2M239.6M142.4M136.7M
Selling, general and administrative201.5M121.0M124.7M71.8M39.7M
Operating income-467.4M-413.5M-411.2M-236.1M-196.0M
Depreciation and amortization47.1M46.9M45.6M31.0M30.2M
EBITDA-420.2M-366.6M-365.6M-205.1M-165.8M
Interest expense2.04M2.26M2.56M1.36M1.52M
Income before tax-452.7M-395.1M-401.2M-231.3M-189.0M
Income tax112.0K2.00K-1.14M-14.0K
Net income-423.9M-389.4M-398.8M-230.1M-189.0M
Earnings per share, basic-0.36-0.34-0.43-0.29-0.28

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents306.7M427.4M167.7M172.4M115.8M
Short-term investments1.00B708.8M938.1M536.0M
Receivables6.01M4.31M7.93M6.41M10.6M
Inventory6.62M6.18M3.76M4.58M4.24M
Current assets1.33B1.16B1.13B725.4M131.8M
Total assets2.11B1.74B1.42B1.04B393.9M
Accounts payable5.70M4.47M6.99M5.57M3.15M
Current liabilities309.0M321.4M89.3M57.2M44.2M
Total debt237.4M364.8M172.6M202.8M141.1M
Total liabilities418.3M458.6M236.8M229.8M169.0M
Shareholders' equity1.42B1.18B1.17B800.9M224.9M
Shares outstanding1.17B1.14B925.2M784.5M665.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-281.3M-260.1M-180.0M-155.7M-108.5M
Capital spending-227.6M-264.0M-16.5M-8.49M-14.5M
Free cash flow-508.9M-524.1M-196.5M-164.2M-123.0M
Cash from investing-497.1M-95.5M-419.6M-536.0M83.9M
Cash from financing657.8M615.3M594.9M748.3M-4.56M
Share buybacks0-800.0K0
Change in cash-120.7M259.7M-4.73M56.6M-29.2M

Open Financials

Cap table

Built by 6ix from PELL Bio-Med Technology Co Ltd’s releases

Common shares
1,311,000,000
Fully diluted
1,311,000,000

Fully diluted

LineShares
Common shares1,311,000,000

Share count over time

CountShares
Nov 22, 20261,311,000,000

Open Cap table

Shareholders

Register

HolderSharesOf the companyAs of
緯創生技投資控股股份有限公司120M9.1%Oct 31, 2026
立準投資有限公司83.5M6.4%Oct 31, 2026
林成龍56M4.3%Oct 31, 2026
宏碁股份有限公司37.2M2.8%Oct 31, 2026
簡文斌1.28M0.10%Oct 31, 2026
許家慧300K0.02%Oct 31, 2026
王銘鈺00.00%Oct 31, 2026
陳志賢00.00%Oct 31, 2026
游智瓊00.00%Oct 31, 2026
李孟修00.00%Oct 31, 2026
All 15 holders
HolderSharesOf the companyAs of
林文榮00.00%Oct 31, 2026
林福謙00.00%Oct 31, 2026
孫維欣00.00%Oct 31, 2026
洪(日告)庭00.00%Oct 31, 2026
緯創生技投資控股股份有限公司Nov 21, 2026

Open Shareholders

Log in to ask 6ix AI your own questions about PELL Bio-Med Technology Co Ltd.